Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies

Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies

BackgroundCardiovascular biomarkers are crucial for monitoring cancer therapy-related cardiac toxicity, but the effects on early stage are still inadequate. To screen biomarkers in patients with breast cancer who receive anthracycline-containing chemotherapy, we studied the behavior of six biomarker...

Full description

Saved in:
Bibliographic Details
Main Authors: Cuncun Chen, Hui Zheng, Yanchun Wang, Ying Tong, Heng Zhang, Suhong Xie, Xiaolu Ma, Minglei Jiang, Zhiyun Gong, Tianqing Yan, Yanan Tian, Lin Guo, Renquan Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
soluble ST2
NT-ProBNP
cardiac toxicity
arrhythmia
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1477679/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1477679/full

Similar Items